Screening for hepatocellular carcinoma—or primary liver cancer—was found to have significant limitations in two recent studies. According to News-Medical.net, randomized studies of hepatocellular carcinoma screening are not feasible because most patients prefer surveillance over non-screening. Additionally, screening for liver cancer at three-month intervals versus six-month intervals did not ...